A patented, scientifically formulated growth factor cocktail clinically proven to reduce hair fall and stimulate regrowth.
Experiencing hair thinning or early-stage hair loss? NeoHair QR678 Therapy is an advanced treatment that uses a specialised growth factor formulation to stimulate hair follicles and promote natural hair regrowth. By improving scalp health and strengthening hair roots, this therapy helps reduce hair fall and enhance hair density over time.

Neohair QR678 is a patented hair growth formula developed by Mumbai-based dermatologists, containing a scientifically optimised blend of growth factors — including VEGF, bFGF, KGF, and IGF-1 — that have been specifically selected and proportioned to stimulate hair follicle regeneration and reverse the miniaturisation process in androgenetic alopecia. Unlike standard mesotherapy or PRP, QR678 uses a standardised, reproducible formulation with documented clinical evidence supporting its efficacy. When injected into the scalp, the QR678 cocktail directly activates follicle stem cells, improves scalp vascularity, and significantly reduces hair fall within the first few sessions — making it a well-regarded option for patients seeking a proven, ready-to-use growth factor treatment.
QR678 is suitable for individuals with androgenetic alopecia, diffuse hair thinning, or stress-related hair loss in both men and women. Its patented formulation and clinical evidence base make it particularly appealing to patients who want a scientifically validated, standardised growth factor treatment. Those who prefer a non-blood-collection treatment option will also find QR678 advantageous. A dermatologist consultation confirms suitability and determines the appropriate treatment schedule.
QR678 delivers a precise, clinically validated growth factor cocktail in a consistent, reproducible dose with each session — unlike PRP or GFC, where the quality of the preparation may vary. Patients typically notice a significant reduction in hair fall within the first few sessions, and progressive improvement in hair density over the full treatment course. The treatment has been studied in peer-reviewed research with documented positive outcomes for both male and female pattern hair loss.
Wash your scalp on the day of treatment. No blood draw is required for QR678, simplifying the pre-treatment process. Avoid applying heavy oils or serums to the scalp before your appointment. Inform your dermatologist of any current hair loss treatments or medications so that these can be incorporated into your overall management plan.
A topical scalp anaesthetic is applied before the procedure. The QR678 solution is administered through a series of precise scalp injections across the thinning zones using a fine needle or mesotherapy gun. Each session takes approximately 20–30 minutes. Mild scalp redness or sensitivity may occur immediately after and resolves quickly.
Avoid washing the scalp for 12 hours after treatment. Refrain from vigorous exercise and direct sun exposure for 24 hours. Continue any prescribed topical or oral hair loss treatments as directed. A gentle, scalp-friendly hair care routine is recommended between sessions.
QR678 therapy has a strong safety record with a well-tolerated injection experience. Temporary scalp redness and mild tenderness at injection sites resolve promptly. No blood collection is required, reducing the preparation time and discomfort associated with autologous treatments.
The cost per session and the full course pricing will be discussed at your consultation. QR678 is typically delivered as a course of six to eight sessions for optimal results. A personalised plan will be provided by Dr. Rajat Kandhari.
Looking for a clinically validated, patent-backed hair loss treatment in Delhi? Book a consultation with Dr. Rajat Kandhari for Neohair QR678 Therapy — a scientifically formulated growth factor cocktail with documented clinical evidence for reducing hair fall and improving hair density. A standardised, reproducible, and effective option for both male and female pattern hair loss.
QR678 is a patented blend of growth factors including VEGF, bFGF, KGF, and IGF-1, formulated to stimulate hair follicle stem cells, reduce miniaturisation, and improve scalp vascularity.
Yes. QR678 has peer-reviewed clinical research supporting its efficacy for androgenetic alopecia in both men and women.
No. Unlike PRP and GFC, QR678 is a ready-to-use formulation that does not require blood collection, simplifying the treatment process.
A typical course consists of six to eight sessions, often spaced one to two weeks apart initially, followed by maintenance sessions.
Yes. It works well alongside PRP, GFC, Hair Mesotherapy, or medical hair loss management as part of a comprehensive programme.
Many patients notice a significant reduction in hair fall after the first two to three sessions. Visible improvement in density develops over the full treatment course.
Yes. QR678 has documented efficacy for female pattern hair loss and diffuse thinning in women.
Dr. Rajat Kandhari uses QR678 as part of a personalised hair restoration strategy, combining the standardised formulation with expert scalp assessment and complementary treatments for optimal outcomes.
WhatsApp us